Bluechiip Limited (AU:BCT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Bluechiip Limited reported modest sales and cash receipts in the final quarter of FY24, with an expansion sale to a major biotech company and a new UK distribution partnership. The company is also undertaking a strategic review, considering partnerships or a sale, while implementing cost-cutting measures and securing additional funding through shareholder loans and an R&D advance facility.
For further insights into AU:BCT stock, check out TipRanks’ Stock Analysis page.
